...contact Kevin Stacey at 773-834-0386 or kstacey@p...BOUT THEIR INTENTIONS? , An article by Princeton...l signals an intent to attack, chances are it,s no... tested previous mathematical models that predict ...nest signals about their intentions. Some models s...
...an any other terrestrial ecosystem. A new report i...not only do trees in intact African tropical fores... than they did 40 years ago--a hopeful sign that t...ing. In a companion article, Helene Muller-Landau,...rch Institute, says that understanding the causes ...
... scientists everywhere to collaborate on the ident... described in the open access journal BMC Biology...nomy. , The multilocus sequence analysis website,...l team of researchers coordinated by Professor Bri...Bacteria are currently assigned to species by cumb...
Other Biology News:Honest crabs, power to the hungry, nice mice and clever meerkats: News from the American Naturalist 2Honest crabs, power to the hungry, nice mice and clever meerkats: News from the American Naturalist 3Cleaning the atmosphere of carbon: African forests out of balance 2(Date:11/24/2009)... Health care employment grew by 29,000 jobs in Oc...consistent growth during the U.S. recession. Howev...ble, and health systems are coming closer to havin...st administrators. , (Voc...ntinued growing in October despite the shedding of...
(Date:11/24/2009)...I, Nov. 24 /PRNewswire-Asia/ -- NOD Pharmaceutical...ice (PTO) has allowed the patent application for,i..., NOD technology is a highly efficient ap...o-adhesive nano-particles to enable oral delivery ... technology is a platform technology,that can be a...
(Date:11/24/2009)...HAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolaxy...istration (SFDA) has approved the,investigational ...oject,(Nodlin), an innovative insulin formulation ...y to initiate its first phase I clinical study. ,...high blood glucose and poor,metabolism. The compli...
(Date:11/24/2009)...The FBI recently approved the Promega PowerPlex 16...n or generating DNA records for the National DNA I...I USA (PRWEB) -- The FBI recently approved the Pro...ratories participating in, or generating DNA recor... currently contains more than seven million profil...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2... CITY, New Jersey, November 26, Rosetta Genomics (...third quarter financial results on December 5, 200...will host a conference call with a,simultaneous we...Friday,December 5. , To access the live conf...al 1-866-966-5335; international participants may ...
...E, Nov. 26 Spectrum,Pharmaceuticals, Inc. (Nasdaq...CTIC )(MTA: CTIC) announced today they have entere...nture, RIT Oncology LLC, to commercialize and,deve... United States.,ZEVALIN, a radioimmunotherapeutic ...by Cell Therapeutics, Inc. (CTI) for the treatment...
...Equels, President and Managing,Director of the Equ...ectors,for Hemispherx BioPharma, Inc. (Amex: HEB... engaged in the manufacture and clinical developme... and immune-based disorders. , Equels, legal...r emphasis,on civil racketeering, business torts a...
Other Biology Technology:Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results 2Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 2Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 3Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 4Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 5Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 6Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 7Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 8Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors 2Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors 3Stirbar, Trans-Blot Plus cell from Bio-Rad
Super Cooling Coil, Trans-Blot cell from Bio-Rad
Criterion Staining and Blotting Trays, with lids, 12 from Bio-Rad
...ting a wide range of next-generation features into...andard for flexible laboratory solutions. It puts ...ng, dilution, dispensing, and integrations into a...exible as it is efficient and economical. The Biom...
Biology Products: